Skip to main content

Table 2 Cancer treatment characteristics and bivariate test of association with SF-36 Physical Component Summary (PCS) and Mental Component Summary (MCS) Scores (N = 331)

From: Co-morbidity and predictors of health status in older rural breast cancer survivors

Characteristic n (%) SF-36 PCS, SF-36 MCS,
mean (SD) mean (SD)
Months since end of treatment *   P = 0.709 P = 0.091
≤12 66 (20.4) 43.84 (11.04) 46.43 (12.59)
13-24 181 (56.1) 45.12 (10.43) 50 (11.49)
25+ 76 (23.5) 44.71 (11.27) 49.82 (11)
Surgery received   P = 0.941 P = 0.009
Lumpectomy 201 (60.7) 44.81 (11.14) 50.32 (10.88)
Mastectomy 98 (29.6) 44.72 (10.01) 48.94 (11.84)
Bilateral mastectomy 32 (9.7) 44.11 (10.13) 43.59 (14.11)
Chemotherapy   P = 0.851 P = 0.004
No 158 (47.7) 44.83 (10.55) 51.17 (11.59)
Yes 173 (52.3) 44.61 (10.86) 47.52 (11.43)
Radiation   P = 0.906 P = 0.063
No 97 (29.3) 44.61 (10.16) 47.4 (13.4)
Yes 234 (70.7) 44.76 (10.93) 50.02 (10.78)
Hormonal therapy a   P = 0.496 P = 0.446
No 113 (34.1) 44.16 (11.15) 48.59 (13.37)
Yes 218 (65.9) 45.01 (10.47) 49.62 (10.64)
Treatment mix   P = 0.184 P = 0.002
Surgery only 50 (15.1) 46.68 (9.7) 50.96 (12.71)
Surgery, chemotherapy 47 (14.2) 42.4 (10.28) 43.61 (13.21)
Surgery, radiation 108 (32.6) 44 (10.86) 51.27 (11.11)
Surgery, chemo, radiation 126 (38.1) 45.42 (10.99) 48.95 (10.41)
  1. Notes: P-values from ANOVA tests; * Counts < 331 due to missing responses;
  2. aOn hormonal treatment at the time the data were collected.